미숙아의 효과적인 조기 정맥영양
Early Effective Parenteral Nutrition for Preterm Infants
4
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Mimicking fetal nutrition is the goal of early paretneral nutrition (PN) in very low birth weight infants, however the limited metabolic capacity of immature organs raises concern about the toxicity of metabolites to the developing brain. Starting parenteral amino acids from the first day of life, with a rate of 1.0 to 1.5 g/kg/day, is generally recommended to prevent endogenous protein breakdown by maintaining a positive nitrogen balance. A greater of amino acid infusion rate in the range of the fetal transfer rate (3.5-4.0 g/kg/day) is well tolerated during the early days after birth in VLBWI, however the influence on growth and long-term neurodevelopmental outcome remains unknown. Limited data are available from controlled trials regarding the effects of early supplementation with lipid emulsions on neonatal morbidity. Considering the role of long-chain polyunsaturated fatty acids in the neurodevelopment, the choice of an optimal lipid emulsion should be based on the quality as well as the quantity of the lipid contents. Little is known about the clinical benefit of higher rates of glucose infusion by permitting high serum glucose level or co-administration with insulin.
Abstract
Mimicking fetal nutrition is the goal of early paretneral nutrition (PN) in very low birth weight infants, however the limited metabolic capacity of immature organs raises concern about the toxicity of metabolites to the developing brain. Starting parenteral amino acids from the first day of life, with a rate of 1.0 to 1.5 g/kg/day, is generally recommended to prevent endogenous protein breakdown by maintaining a positive nitrogen balance. A greater of amino acid infusion rate in the range of the fetal transfer rate (3.5-4.0 g/kg/day) is well tolerated during the early days after birth in VLBWI, however the influence on growth and long-term neurodevelopmental outcome remains unknown. Limited data are available from controlled trials regarding the effects of early supplementation with lipid emulsions on neonatal morbidity. Considering the role of long-chain polyunsaturated fatty acids in the neurodevelopment, the choice of an optimal lipid emulsion should be based on the quality as well as the quantity of the lipid contents. Little is known about the clinical benefit of higher rates of glucose infusion by permitting high serum glucose level or co-administration with insulin.
참고문헌 (54)
- Lemons JA, "Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996", Pediatrics, 107, pp.E1~ (2001), NICHD Neonatal Research Network
- McClellan R, "Fetal nutrition: how we become what we are", J Pediatr Gastroenterol Nutr, 33, pp.233~244 (2001)
- Hanebutt FL, "Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta", Clin Nutr, 27, pp.685~693 (2008)
- Herrera E, "Maternal lipid metabolism and placental lipid transfer", Horm Res, 65(3), pp.59~64 (2006)
- Gudinchet F, "Metabolic cost of growth in very low-birth-weight infants", Pediatr Res, 16, pp.1025~1030 (1982)
- Uthaya S, "Altered adiposity after extremely preterm birth", Pediatr Res, 57, pp.211~215 (2005)
- Singhal A, "Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials", Lancet, 357, pp.413~419 (2001)
- Singhal A, "Is slower early growth beneficial for long-term cardiovascular health?", Circulation, 109, pp.1108~1113 (2004)
- Singhal A, "Low nutrient intake and early growth for later insulin resistance in adolescents born preterm", Lancet, 361, pp.1089~1097 (2003)
- Kalhan S, "Effect of intravenous amino acids on protein kinetics in preterm infants", Curr Opin Clin Nutr Metab Care, 10, pp.69~74 (2007)
- Bohe J, "Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids", J Physiol, 532, pp.575~579 (2007)
- Darmaun, "Noninvasive techniques to monitor nutrition in neonates. in: Neonatology Questions and Controversies. 1st ed" (2008), Saunders, Elsevier
- Denne SC, "Effect of intravenous glucose and lipid on proteolysis and glucose production in normal newborns", Am J Physiol, 269, pp.E361~E367 (1995)
- Fukagawa NK, "Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men", J Clin Invest, 76, pp.2306~2311 (1985)
- Poindexter BB, "Amino acids suppress proteolysis independent of insulin throughout the neonatal period", Am J Physiol, 272, pp.E592~E599 (1997)
- Tessari P, "Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine- carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition", J Clin Invest, 79, pp.1062~1069 (1987)
- Kadrofske MM, "Effect of intravenous amino acids on glutamine and protein kinetics in low-birth-weight preterm infants during the immediate neonatal period", Am J Physiol Endocrinol Metab, 290, pp.E622~E630 (2006)
- te Braake FW, "Parenteral amino acid and energy administration to premature infants in early life", Semin Fetal Neonatal Med, 12, pp.11~18 (2007)
- Embleton ND, "Optimal protein and energy intakes in preterm infants", Early Hum Dev, 83, pp.831~837 (2007)
- Adamkin DH, "Nutrition Management of the Very Low-birthweight Infant: I. Total Parenteral Nutrition and Minimal Enteral Nutrition", Neoreviews, 7, pp.e602~e607 (2006)
- Koletzko B, "Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR)", J Pediatr Gastroenterol Nutr, 41(2), pp.S1~S87 (2005)
- Mrozek JD, "Effect of sepsis syndrome on neonatal protein and energy metabolism", J Perinatol, 20, pp.96~100 (2000)
- Zlotkin SH, "Intravenous nitrogen and energy intakes required to duplicate in utero nitrogen accretion in prematurely born human infants", J Pediatr, 99, pp.115~120 (1981)
- Kashyap S, "Growth, nutrient retention, and metabolic response in low birth weight infants fed varying intakes of protein and energy", J Pediatr, 113, pp.713~721 (1988)
- Saenz de Pipaon M, "Effect of two amino acid solutions on leucine turnover in preterm infants", Biol Neonate, 87, pp.236~241 (2005)
- Wilson DC, "Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants", Arch Dis Child Fetal Neonatal Ed, 77, pp.F4~F11 (1997)
- Thureen PJ, "Effect of low versus high intravenous amino acid intake on very low birth weight infants in the early neonatal period", Pediatr Res, 53, pp.24~32 (2003)
- te Braake FW, "Amino acid administration to premature infants directly after birth", J Pediatr, 147, pp.457~461 (2005)
- Poindexter BB, "Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcome", J Pediatr, 148, pp.300~305 (2006)
- Clark RH, "Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial", Pediatrics, 120, pp.1286~1296 (2007)
- Maggio L, "Effects of high versus standard early protein intake on growth of extremely low birth weight infants", J Pediatr Gastroenterol Nutr, 44, pp.124~129 (2007)
- Stephens BE, "First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants", Pediatrics, 123, pp.1337~1343 (2009)
- Dinerstein A, "Early and aggressive nutritional strategy (parenteral and enteral) decreases postnatal growth failure in very low birth weight infants", J Perinatol, 26, pp.436~442 (2006)
- Ibrahim HM, "Aggressive early total parental nutrition in low-birth-weight infants", J Perinatol, 24, pp.482~486 (2004)
- Kotsopoulos K, "Safety and efficacy of early amino acids in preterm <28 weeks gestation: prospective observational comparison", J Perinatol, 26, pp.749~754 (2006)
- Blanco CL, "Metabolic responses to early and high protein supplementation in a randomized trial evaluating the prevention of hyperkalemia in extremely low birth weight infants", J Pediatr, 153, pp.535~540 (2008)
- Clandinin MT, "Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid", J Pediatr, 146, pp.461~468 (2005)
- Clandinin MT, "Fatty acid utilization in perinatal de novo synthesis of tissues", Early Hum Dev, 5, pp.355~366 (1981)
- Lehner F, "Metabolic effects of intravenous LCT or MCT", LCT lipid emulsions in preterm infants, 2006, pp.47, 404~411
- Driscoll DF, "Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology", Clin Nutr, 27, pp.497~503 (2008)
- Deckelbaum RJ, "Intravenous lipid emulsions in pediatrics: time for a change?", J Pediatr Gastroenterol Nutr, 37, pp.112~114 (2003)
- Gura KM, "Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition- associated liver disease", Pediatrics, 121, pp.e678~e686 (2008)
- Sosenko IR, "Polyunsaturated fatty acids and protection of newborn rats from oxygen toxicity", J Pediatr, 112, pp.630~637 (1988)
- Sosenko IR, "Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants", J Pediatr, 123, pp.975~982 (1993)
- Simmer K, "Early introduction of lipids to parenterally-fed preterm infants", Cochrane Database Syst Rev, 2, pp.CD005256~ (2005)
- Kairamkonda VR, "Controversies in the management of hyperglycemia in the ELBW infant", Indian Pediatr, 45, pp.29~38 (2008)
- Van den Berghe G, "Intensive insulin therapy in the medical ICU", N Engl J Med, 354, pp.449~461 (2006)
- Klein GW, "Hyperglycemia and outcome in the pediatric intensive care unit", J Pediatr, 153, pp.379~384 (2008)
- Arabi YM, "Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients", Crit Care Med, 36, pp.3190~3197 (2008)
- Hays SP, "Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants", Pediatrics, 118, pp.1811~1818 (2006)
- Meetze W, "Hyperglycemia in extremely- low-birth-weight infants", Biol Neonate, 74, pp.214~221 (1998)
- Collins JW Jr, "A controlled trial of insulin infusion and parenteral nutrition in extremely low birth weight infants with glucose intolerance", J Pediatr, 118, pp.921~927 (1991)
- Beardsall K, "Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants", J Pediatr, 151, pp.611~617 (2007)
- Beardsall K, "Early insulin therapy in very-low-birth-weight infants", N Engl J Med, 359, pp.1873~1884 (2008)